Cognitive deficits in preclinical Alzheimer's disease
Brent J. Small
Department of Gerontology, University of South Florida, Tampa, FL, USA;
Search for more papers by this authorJennifer L. Mobly
Department of Gerontology, University of South Florida, Tampa, FL, USA;
Search for more papers by this authorErika Jonsson Laukka
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorSari Jones
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorLars Bäckman
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorBrent J. Small
Department of Gerontology, University of South Florida, Tampa, FL, USA;
Search for more papers by this authorJennifer L. Mobly
Department of Gerontology, University of South Florida, Tampa, FL, USA;
Search for more papers by this authorErika Jonsson Laukka
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorSari Jones
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorLars Bäckman
Department of Psychology, Uppsala University, Uppsala, Sweden;
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorAbstract
We review the literature on cognitive functioning during the transition from normal aging to clinical Alzheimer's disease (AD). There is ample empirical evidence that deficits across multiple cognitive domains are apparent years to decades before the AD diagnosis, with impairments in episodic memory representing a common cognitive manifestation of the preclinical phase of the disease. Interestingly, the magnitude of the preclinical cognitive deficits appears to be relatively stable until a few years before clinical diagnosis. The behavioural deficits associated with preclinical AD are consistent with the neural changes that appear many years before eventual diagnosis. In addition to increasing our theoretical understanding of AD development, research on cognition in preclinical AD contributes to the identification of persons at risk of developing AD for purposes of intervention.
References
- 1 Schenk D, Barbour R, Dunn W et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173–7.
- 2 Jacobs DM, Sano M, Dooneif G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 317–24.
- 3 Elias MF, Beiseries A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer's disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000; 57: 808–13.
- 4 Small BJ, Viitanen M, Bäckman L. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: Incidence data from the Kungsholmen project, Stockholm. J Geront Med Sci 1997; 52: 299–304.
- 5 Tierney MC, Szalai JP, Snow WG et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1995; 46: 661–5.
- 6
Johansson B,
Zarit SH.
Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old.
Int J Geriatr Psychiatr
1997; 12: 53–9.
10.1002/(SICI)1099-1166(199701)12:1<53::AID-GPS507>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 7 Aronson MK, Ooi WL, Morgenstern H et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990; 40: 1102–6.
- 8 Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995; 45: 1161–8.
- 9 Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1995; 44: 1427–32.
- 10 Fabrigoule C, Rouch I, Taberly A et al. Cognitive processes in preclinical phase of dementia. Brain 1998; 121: 135–41.
- 11 Linn RT, Wolf PA, Bachman DL et al. The ‘preclinical phase’ of probable Alzheimer's disease. Arch Neurol 1995; 52: 485–90.
- 12 Fabrigoule C, Lafont S, Letenneur L et al. WAIS similarities subtest performances as predictors of dementia in elderly community residents. Brain Cognit 1996; 30: 323–6.
- 13 Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997; 45: 584–9.
- 14 Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Bäckman L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 1997; 11: 413–20.
- 15 Grober E, Lipton RB, Hall C, Crystal H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000; 54: 827–32.
- 16 Bäckman L, Small BJ. Influences of cognitive support on episodic remembering: Tracing the process of loss from normal aging to Alzheimer's disease. Psychol Aging 1998; 13: 267–76.
- 17 Fuld PA, Masur DM, Blau AD, Crystal HA, Aronson MK. Object-memory evaluation for prospective detection of dementia in normal functioning elderly. J Clin Exp Neuropsychol 1990; 12: 520–8.
- 18 Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001; 124: 96–102.
- 19 Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L. The course of cognitive impairment in preclinical Alzheimer's disease: 3- and 6-year follow-up of a population-based sample. Arch Neurol 2000; 57: 839–44.
- 20 La Rue A, Jarvik LF. Cognitive function and prediction of dementia in old age. Int J Aging Hum Dev 1987; 25: 75–89.
- 21 Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996; 275: 528–32.
- 22 Whalley LJ, Starr JM, Athawes R, Hunter D, Pattie A, Deary IJ. Childhood mental ability and dementia. Neurology 2000; 55: 1455–9.
- 23 Fox NC, Warrington EK, Freeborough PA et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 1996; 119: 2001– 7.
- 24 Goldman WP, Price JL, Storandt M et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology 2001; 56: 361–7.
- 25 Chen P, Ratcliff G, Belle SH, Cauley JA, Dekosky ST, Ganguli M. Patterns of decline in pre-symptomatic Alzheimer's Disease: a prospective community study. Arch Gen Psychiatr 2001; 58: 853–8.
- 26 Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance imaging. Lancet 2001; 358: 201–5.
- 27 Killiany RJ, Gomez-Isla T, Moss M et al. Imaging to predict who will get Alzheimer's disease. Ann Neurol 2000; 47: 430–9.
- 28 Silverman DHS, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 2001; 286: 2120–7.
- 29 De Leon MJ, George AE, Golomb J et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997; 18: 1–11.
- 30 Xu Y, Jack CR Jr, O'Brien PC et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000; 54: 1760– 7.
- 31 Jack CR Jr, Petersen RC, Xu YC et al. Prediction of AD with MRI-based hippocampal Volume in mild cognitive impairment. Neurology 1999; 52: 1397–403.
- 32 Squire LR. Memory and Brain. New York: Oxford University Press, 1987.
- 33 Vargha-Khadem F, Gadian DG, Watkins KE, Connelly A, Van Paesschen W, Mishkin M. Differential effects of early hippocampal lesions on episodic and semantic memory. Science 1997; 277: 376–80.
- 34 Laakso MP, Soininen H, Partanen K et al. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1997; 19: 23–31.
- 35 Cabeza R, Nyberg L. Imaging cognition II. An empirical review of 275 PET and fMRI studies. J Cognit Neurosci 2000; 12: 1–47.
- 36 Langley LK, Madden DJ. Functional neuroimaging of memory: Implications for cognitive aging. Microscopy Res Technique 2000; 51: 75–84.
- 37 Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001; 17: 101–18.
- 38 Morris JC, Storandt M, McKeel DW Jr et al. Cerebral amyloid deposition and diffuse plaques in ‘normal’ aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996; 46: 707–19.
- 39 Salat DH, Kaye JA, Janowsky JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 2001; 58: 1403–8.
- 40 Wheeler MA, Stuss DT, Tulving E. Frontal lobe damage produces episodic memory impairment. JINS 1995; 1: 525–36.
- 41 Braver TS, Barch DM, Keys BA et al. Context processing in older adults: Evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen 2001; 130: 746–63.
- 42 Li S-C, Lindenberger U, Sikstrom S. Aging cognition: From neuromodulation to representation. TICS 2001; 5: 479–86.